Skip to content
10-K

Annual Report

TAMIR BIOTECHNOLOGY, INC.

0001308411-13-000092

← back to feed
Filed
Apr 25, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2011 · Jul 31, 2010 47.31M sh
Capex FY 2011 · Jul 31, 2010 $2.75K
Operating Cash Flow FY 2011 · Jul 31, 2010 −$2.82M
Current Liabilities FY 2011 · Jul 31, 2010 $17M
Total Liabilities FY 2011 · Jul 31, 2010 $23.86M
Current Assets FY 2011 · Jul 31, 2010 $2.03M
Total Assets FY 2011 · Jul 31, 2010 $2.24M
Eps Diluted FY 2011 · Jul 31, 2010 −$0.30
Eps Basic FY 2011 · Jul 31, 2010 −$0.30
Sga Expense FY 2011 · Jul 31, 2010 $1.7M
Rd Expense FY 2011 · Jul 31, 2010 $517.87K
Net Income FY 2011 · Jul 31, 2010 −$14.19M
Operating Income FY 2011 · Jul 31, 2010 −$2.2M
Revenue FY 2011 · Jul 31, 2010 $18.75K
Cash And Equivalents FY 2011 · Jul 31, 2009 $129.19K
Stockholders Equity FY 2011 · Jul 31, 2009 −$7.15M